FDA approves Lundbeck's antidepressant Brintellix By: Reuters: Company News September 30, 2013 at 18:24 PM EDT Sept 30 (Reuters) - The U.S. Food and Drug Administration approved Lundbeck's antidepressant Brintellix to treat adults with major depressive disorder. Read More >> Related Stocks: Lundin Mining Corporation